Author:
Mezynski J.,Pezaro C.,Bianchini D.,Zivi A.,Sandhu S.,Thompson E.,Hunt J.,Sheridan E.,Baikady B.,Sarvadikar A.,Maier G.,Reid A.H.M.,Mulick Cassidy A.,Olmos D.,Attard G.,de Bono J.
Funder
Cancer Research UK programme grant
Cancer Research UK and the Department of Health
National Institute for Health Research
Prostate Cancer Foundation
NIHR
Reference21 articles.
1. Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2008, England,2010
2. Statistical Bulletin: Death Registrations by Cause in England and Wales, 2009,2010
3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
4. The mechanism of action of docetaxel (Taxotere) in xenograft models is not limited to bcl-2 phosphorylation;Kraus;Invest New Drugs,2003
5. Targeting the androgen receptor by Taxol in castration-resistant prostate cancer;Jiang;Mol Cell Pharmacol,2010
Cited by
219 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献